HK1030338A1 - Treatment of schizophrenia with ampakines and neuroleptics - Google Patents
Treatment of schizophrenia with ampakines and neurolepticsInfo
- Publication number
- HK1030338A1 HK1030338A1 HK01101109A HK01101109A HK1030338A1 HK 1030338 A1 HK1030338 A1 HK 1030338A1 HK 01101109 A HK01101109 A HK 01101109A HK 01101109 A HK01101109 A HK 01101109A HK 1030338 A1 HK1030338 A1 HK 1030338A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- schizophrenia
- treatment
- ampakines
- neuroleptics
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6362797P | 1997-10-27 | 1997-10-27 | |
PCT/US1998/022707 WO1999021422A1 (en) | 1997-10-27 | 1998-10-26 | Treatment of schizophrenia with ampakines and neuroleptics |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1030338A1 true HK1030338A1 (en) | 2001-05-04 |
Family
ID=22050462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01101109A HK1030338A1 (en) | 1997-10-27 | 2001-02-15 | Treatment of schizophrenia with ampakines and neuroleptics |
Country Status (15)
Country | Link |
---|---|
US (1) | US6166008A (el) |
EP (1) | EP1026950B1 (el) |
JP (1) | JP2001520978A (el) |
CN (1) | CN1281335A (el) |
AT (1) | ATE317226T1 (el) |
AU (1) | AU745641B2 (el) |
BR (1) | BR9814106A (el) |
CA (1) | CA2306817A1 (el) |
CY (1) | CY1105557T1 (el) |
DE (1) | DE69833451T2 (el) |
DK (1) | DK1026950T3 (el) |
ES (1) | ES2258825T3 (el) |
HK (1) | HK1030338A1 (el) |
PT (1) | PT1026950E (el) |
WO (1) | WO1999021422A1 (el) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2174851T3 (es) | 1992-07-24 | 2002-11-16 | Univ California | Farmacos que aumentan las respuestas sinapticas mediadas por receptores ampa. |
US20040229898A1 (en) * | 2001-05-25 | 2004-11-18 | The Regents Of The University Of California | Cyclic bis-compounds clearing malformed proteins |
WO2002096431A1 (en) * | 2001-05-25 | 2002-12-05 | The Regents Of The University Of California | Optically active compounds clearing malformed proteins |
EP1423103A4 (en) * | 2001-08-10 | 2008-03-19 | Univ Rockefeller | COMPOSITIONS AND METHOD FOR MODULATING DARPP-32 PHOSPHORYLATION |
BRPI0406736A (pt) * | 2003-01-13 | 2005-12-20 | Cortex Pharma Inc | Método de tratar declìnico cognitivo devido à privação de sono e estresse |
WO2005013961A1 (en) * | 2003-07-17 | 2005-02-17 | Eli Lilly And Company | Combination therapy for treatment of cognitive disorders or psychoses |
NZ527142A (en) * | 2003-07-23 | 2006-03-31 | Douglas Pharmaceuticals Ltd | A stable suspension formulation |
US7282519B2 (en) | 2003-08-28 | 2007-10-16 | Nitromed, Inc. | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
GB0325175D0 (en) * | 2003-10-28 | 2003-12-03 | Novartis Ag | Organic compounds |
JP2007519733A (ja) * | 2004-01-26 | 2007-07-19 | コーテックス ファーマシューティカルズ インコーポレーティッド | アンパカインにより誘導されるシナプス応答促通のコリンエステラーゼ阻害剤による増強方法 |
CA2571243A1 (en) | 2004-06-21 | 2006-01-05 | The Board Of Trustees Of The Leland Stanford Junior University | Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder |
US20060063707A1 (en) * | 2004-09-17 | 2006-03-23 | Lifelike Biomatic, Inc. | Compositions for enhancing memory and methods therefor |
CA2580694A1 (en) * | 2004-09-23 | 2006-03-30 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
JP2008531579A (ja) * | 2005-02-24 | 2008-08-14 | ニトロメッド インコーポレーティッド | 酸化窒素増強利尿化合物、組成物および使用方法 |
SI2332909T1 (sl) | 2005-04-13 | 2015-01-30 | Astex Therapeutics Limited | Derivati hidroksibenzamida in njih uporaba kot inhibitorji hsp90 |
KR20060119373A (ko) * | 2005-05-20 | 2006-11-24 | 엘지전자 주식회사 | 컴퓨터 시스템과 시스템 소프트웨어 설치방법 및 휴대용컴퓨터의 소프트웨어 설치방법 |
CA2629299C (en) | 2005-11-12 | 2017-08-22 | The Board Of Trustees Of The Leland Stanford Junior University | Fgf2-related methods for diagnosing and treating depression |
EP1960373A2 (en) * | 2005-11-22 | 2008-08-27 | NeuroSearch A/S | Novel quinoxaline derivatives and their medical use |
US7754725B2 (en) | 2006-03-01 | 2010-07-13 | Astex Therapeutics Ltd. | Dihydroxyphenyl isoindolymethanones |
US20080176793A1 (en) * | 2006-09-18 | 2008-07-24 | The Regents Of The University Of California | Upregulating activity or expression of bdnf to mitigate cognitive impairment in asymptomatic huntington's subjects |
JP5721949B2 (ja) | 2006-10-12 | 2015-05-20 | アステックス、セラピューティックス、リミテッドAstex Therapeutics Limited | 複合薬剤 |
JP5410285B2 (ja) | 2006-10-12 | 2014-02-05 | アステックス、セラピューティックス、リミテッド | 医薬化合物 |
GB0620259D0 (en) | 2006-10-12 | 2006-11-22 | Astex Therapeutics Ltd | Pharmaceutical compounds |
US9730912B2 (en) | 2006-10-12 | 2017-08-15 | Astex Therapeutics Limited | Pharmaceutical compounds |
EP2073807A1 (en) | 2006-10-12 | 2009-07-01 | Astex Therapeutics Limited | Pharmaceutical combinations |
EP2073803B1 (en) | 2006-10-12 | 2018-09-19 | Astex Therapeutics Limited | Pharmaceutical combinations |
WO2008128166A1 (en) * | 2007-04-13 | 2008-10-23 | Concert Pharmaceuticals Inc. | Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds |
US20090006902A1 (en) * | 2007-06-29 | 2009-01-01 | International Business Machines Corporation | Methods, systems, and computer program products for reporting fru failures in storage device enclosures |
RU2010106975A (ru) | 2007-08-10 | 2011-09-20 | Кортекс Фармасьютикалз, Инк. (Us) | Бициклические амиды для усиления глутаматергических синаптических ответов |
US8168632B2 (en) | 2007-08-10 | 2012-05-01 | Cortex Pharmaceuticals, Inc. | Bicyclic amide derivatives for the treatment of respiratory disorders |
US8071914B2 (en) * | 2007-12-26 | 2011-12-06 | Noboru Oshima | Heating apparatus |
GB0806527D0 (en) | 2008-04-11 | 2008-05-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
SG173168A1 (en) * | 2009-02-02 | 2011-08-29 | Cortex Pharma Inc | Bicyclic amide derivatives for enhancing glutamatergic synaptic responses |
PT105083A (pt) | 2009-04-28 | 2011-07-25 | Univ De Coimbra | Processo para cultura de células estaminais neurais baseado nas ampacinas e/ou outros moduladores de receptores glutamatérgicos ionotrópicos, composições e seu uso em condições do sistema nervoso central |
EP2544688B1 (en) | 2010-03-02 | 2016-09-07 | President and Fellows of Harvard College | Methods and compositions for treatment of angelman syndrome |
AU2012225784B2 (en) | 2011-03-04 | 2016-03-17 | The Regents Of The University Of California | Locally released growth factors to mediate motor recovery after stroke |
US8822464B2 (en) | 2011-11-28 | 2014-09-02 | Boehringer Ingelheim International Gmbh | N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors |
US8741892B2 (en) * | 2011-12-05 | 2014-06-03 | Boehringer Ingelheim International Gmbh | Compounds |
US8796467B2 (en) | 2011-12-13 | 2014-08-05 | Boehringer Ingelheim International Gmbh | Compounds |
US8846948B2 (en) | 2011-12-13 | 2014-09-30 | Boehringer Ingelheim International Gmbh | Compounds |
US8716277B2 (en) | 2011-12-14 | 2014-05-06 | Boehringer Ingelheim International Gmbh | Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity |
US8937176B2 (en) | 2011-12-14 | 2015-01-20 | Boehringer Ingelheim International Gmbh | Compounds |
US8883789B2 (en) | 2011-12-14 | 2014-11-11 | Boehringer Ingelheim International Gmbh | Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors |
US8889677B2 (en) | 2012-01-17 | 2014-11-18 | Boehringer Ingellheim International GmbH | Substituted triazoles useful as mGlu5 receptor modulators |
JP2015520191A (ja) | 2012-06-05 | 2015-07-16 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | Ncamペプチド模倣体を用いた精神障害またはその症状を治療するための方法 |
CR20200553A (es) | 2018-04-18 | 2021-04-08 | Constellation Pharmaceuticals Inc | Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos |
CA3100977A1 (en) | 2018-05-21 | 2019-11-28 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8908085D0 (en) * | 1989-04-11 | 1989-05-24 | Lundbeck & Co As H | New therapeutic use |
US5312819A (en) * | 1990-08-20 | 1994-05-17 | Sandoz Ltd. | Pharmaceutical compositions comprising clozapine and a radical scavenger |
US5447948A (en) * | 1992-05-07 | 1995-09-05 | Yale University | Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia |
GB9507230D0 (en) * | 1995-04-07 | 1995-05-31 | Inst Of Psychiatry | Novel method |
US5650409A (en) * | 1995-06-02 | 1997-07-22 | Cortex Pharmaceuticals, Inc. | Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
US5773434A (en) * | 1995-08-30 | 1998-06-30 | Gary A. Rogers | Facilitation of AMPA receptor-mediated synaptic transmission in brain as a treatment for schizophrenia |
US5736543A (en) * | 1996-04-03 | 1998-04-07 | The Regents Of The University Of California | Benzoxazines for enhancing synaptic response |
-
1998
- 1998-10-26 CN CN98812086A patent/CN1281335A/zh active Pending
- 1998-10-26 EP EP98957382A patent/EP1026950B1/en not_active Revoked
- 1998-10-26 US US09/179,341 patent/US6166008A/en not_active Expired - Lifetime
- 1998-10-26 AT AT98957382T patent/ATE317226T1/de active
- 1998-10-26 ES ES98957382T patent/ES2258825T3/es not_active Expired - Lifetime
- 1998-10-26 WO PCT/US1998/022707 patent/WO1999021422A1/en active IP Right Grant
- 1998-10-26 CA CA002306817A patent/CA2306817A1/en not_active Abandoned
- 1998-10-26 PT PT98957382T patent/PT1026950E/pt unknown
- 1998-10-26 DE DE69833451T patent/DE69833451T2/de not_active Expired - Lifetime
- 1998-10-26 BR BR9814106-6A patent/BR9814106A/pt not_active Application Discontinuation
- 1998-10-26 AU AU13658/99A patent/AU745641B2/en not_active Ceased
- 1998-10-26 DK DK98957382T patent/DK1026950T3/da active
- 1998-10-26 JP JP2000517599A patent/JP2001520978A/ja active Pending
-
2001
- 2001-02-15 HK HK01101109A patent/HK1030338A1/xx not_active IP Right Cessation
-
2006
- 2006-05-04 CY CY20061100571T patent/CY1105557T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2258825T3 (es) | 2006-09-01 |
DK1026950T3 (da) | 2006-06-26 |
DE69833451D1 (de) | 2006-04-20 |
CY1105557T1 (el) | 2010-07-28 |
US6166008A (en) | 2000-12-26 |
ATE317226T1 (de) | 2006-02-15 |
CA2306817A1 (en) | 1999-05-06 |
PT1026950E (pt) | 2006-06-30 |
EP1026950A4 (en) | 2004-07-07 |
AU1365899A (en) | 1999-05-17 |
AU745641B2 (en) | 2002-03-28 |
BR9814106A (pt) | 2000-10-03 |
WO1999021422A1 (en) | 1999-05-06 |
EP1026950B1 (en) | 2006-02-08 |
EP1026950A1 (en) | 2000-08-16 |
CN1281335A (zh) | 2001-01-24 |
DE69833451T2 (de) | 2006-09-28 |
JP2001520978A (ja) | 2001-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1030338A1 (en) | Treatment of schizophrenia with ampakines and neuroleptics | |
DE69429524T2 (de) | Aminocyclohexylester und ihre anwendung | |
DE60024588D1 (de) | Substituierte porphyrine und deren therapeutische verwendungen | |
BG100830A (en) | Naphthylamides as central nervous system agents | |
JO2359B1 (en) | Benzathene derivatives as agents for modulation of GABA A receptor | |
TR200002773T2 (tr) | Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı. | |
MXPA04004714A (es) | Derivados de aril 1,4-pirazina sustituidos. | |
DE69813898D1 (de) | Substituierte porphyrinen | |
IL134089A0 (en) | 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring | |
CA2284551A1 (en) | New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders | |
GB0216865D0 (en) | Targetted agents for nerve regeneration | |
PT1000046E (pt) | Derivados de piperazina activos no trato urinario inferior | |
TW200503717A (en) | Substituted 1,4-pyrazine derivatives | |
WO2001007431A3 (en) | Benzothiophene derivatives | |
MX9700854A (es) | Derivados de azabicicloheptano n-substituidos utiles como neurolepticos. | |
DE60029119D1 (de) | Disulfidkonjugierte zellgifte und verfahren zur ihrer herstellung und verwendung | |
TR200000916T2 (tr) | İkameli piperidin türevleri. | |
CA2180155A1 (en) | Naphthylamides as central nervous system agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CORR | Corrigendum |
Free format text: CORRECTED DATA OF SECTION 27 TO JOURNAL OF : [73] CORTEX PHARMACEUTICALS, INC - 15241 BARRANCA PARKWAY - IRVINE, CA 92718 - UNITED STATES/UNITED STATES OF AMERICA - THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - 12TH FLOOR, 1111 FRANKLIN STREET - OAKLAND - CALIFORNIA 94607-5200 - UNITED STATES/UNITED STATES OF AMERICA - DATED 15.9.2006 |
|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20131026 |